Advertisement

Pap Smear and HPV Testing

Chapter
  • 350 Downloads

Abstract

The Pap smear for cervical cancer screening was first introduced in the 1940s. Since then, the incidence of cervical cancer in the USA has decreased from 14/100,000 to 7.4/100,000 in 2018 (NIH National Cancer Institute. www.seer.cancer.gov). The addition of high-risk human papilloma virus DNA testing (HPV testing) has improved sensitivity for cervical cancer screening. The procedure for Pap smear and HPV testing is discussed, as well as screening recommendations and management guidelines.

Keywords

Pap smear Cervical cancer Cervical dysplasia HPV Human papillomavirus CIN Liquid-based cytology 

References

  1. 1.
    NIH National Cancer Institute. www.seer.cancer.gov.
  2. 2.
    American College of Obstetricians and Gynecologists. Cervical cancer screening and prevention. In: Practice bulletin, vol. 157. Washington, D.C.: ACOG; 2016.Google Scholar
  3. 3.
    Bernstein SJ, Sanchez-Ramos L, Ndubisi B. Liquid-based cervical cytologic smear study and conventional Papsnicolaou smears: a metaanalysis of prospective studies comparing cytologic diagnosis and sample adequacy. Am J Obstet Gynecol. 2001;185:308–17.CrossRefGoogle Scholar
  4. 4.
    Nance KV. Evolution of pap testing at a community hospital – a ten-year experience. Diagn Cytopathol. 2007;35:148–53.CrossRefGoogle Scholar
  5. 5.
    Sweeny BJ, Haq Z, Happel JF, Weinstein B, Schneider D. Comparison of the effectiveness of two liquid based papanicoleau systems in the handling of adverse limiting factors, such as excessive blood. Cancer. 2006;108(1):27–31.CrossRefGoogle Scholar
  6. 6.
    Melnikow J, et al. Screening for cervical cancer with high risk human papilloma virus testing, updated evidence report and systematic review. USPSTF. JAMA. 2018;320(7):687–705.CrossRefGoogle Scholar
  7. 7.
    Saslow D, et al. ACS, ASCCP, and ASCP screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin. 2012;62:147–72.CrossRefGoogle Scholar
  8. 8.
    Massad LS, et al. 2012 ASCCP updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis. 2013;17(5):S1–S27.CrossRefGoogle Scholar
  9. 9.
    Naucler P, Ryd W, Tomberg S, et al. Human papillomavirus and pap tests to screen for cervical cancer. N Engl J Med. 2007;357(16):1589–97.CrossRefGoogle Scholar

Additional Resources

    Articles

    1. Solomon D, Davey D, Kurman R. The 2001 Bethesda System terminology for reporting results of cervical cytology. JAMA. 2002;287:2114–9.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Department of Family MedicineSt. Joseph’s Hospital Health CenterSyracuseUSA

Personalised recommendations